This research is a Randomized, double-blind, placebo-controlled, multicenter clinical study. Chinese subjects with Ischemic Stroke.
Subjects will randomly enter into one of two groups,the period of treatment is 14 days,follow-up to the 90th days.
- Pinocembrin for Injection Drug
Other Names: DL0108 ARM 1: Kind: Experimental Label: Pinocembrin for Injection Description: 40mg /60mg in 100ml of a solution of 0.9 percent saline,iv.drip bid,14day ARM 2: Kind: Experimental Label: placebo Description: 60mg in 100ml of a solution of 0.9 percent saline,iv.drip bid,14day
- Allocation: Randomized
- Masking: Double Blind (Subject, Caregiver, Investigator)
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
|Type||Measure||Time Frame||Safety Issue|
|Primary||To determination the proportion of subjects that 0-1 score of mRS after treatment 90 days||90 days||No|
|Secondary||To compare treatment arms in terms of change from baseline to endpoint in NIHSS score.||90 days||No|